Matches 1 - 50 out of 318 1 2 3 4 5 6 7 >


Match Document Document Title
US20110281892 METHOD AND FORMULATION FOR COLD TREATMENT IN ADULTS AND CHILDREN WITH INCREASED SAFETY  
Methods and dosage formulations for the safe treatment of cold, cough, flu, and sinus symptoms in children and adolescents by age and nature of symptoms, and adults and the elderly by age, nature...
US20130303564 METHOD FOR TREATING A NEURODEGENERATIVE DISORDER  
Provided herein are methods and materials for treating neurodegenerative disorders. The methods may use inhibitors of small G-proteins, such as p21rac, p21ras, or the combination thereof. The...
US20110237563 FAST DISSOLVING DRUG DELIVERY SYSTEMS  
The present invention related to the administration of bioactive agents via oral fast dispersing/dissolving drug delivery systems for treating illnesses of patient with critical buccal condition,...
US20110003781 Non-Sedating Antihistamine Injection Formulations and Methods of Use Thereof  
Described herein are injectable compositions containing non-sedating or second and third generation antihistamines such as cetirizine/levocetirizine and methods of use thereof. Specifically,...
US20090137620 USE OF GALLIUM(III) COMPLEXES FOR THE TREATMENT OF MELANOMAS  
The invention relates to the use of gallium (III) complexes for the treatment of melanomas.
US20110218209 NUTRIENT DELIEVRY DRUG COMPOSITION  
The present invention is a hypoallergenic nutrient delivery drug composition, that includes an active drug, a binder with non-genetically engineered and non-chemically treated starches and food...
US20150132410 COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF ALCOHOL-INDUCED HANGOVER SYNDROME  
The invention provides compositions for the prevention and treatment of the symptoms of alcoholic beverage-induced hangover syndrome, related kits and methods of using the compositions and kits.
US20140194460 TREATMENT OF ENDOMETRIOSIS  
A pharmaceutical composition comprising quinagolide for the treatment and/or prevention of endometriosis.
US20120157489 TREATMENT OF ENDOMETRIOSIS  
A pharmaceutical composition comprising quinagolide for the treatment and/or prevention of endometriosis.
US20150018290 INDUCERS OF HEMATOPOIESIS AND FETAL GLOBIN PRODUCTION FOR TREATMENT OF CYTOPENIAS AND HEMOGLOBIN DISORDERS  
The present invention generally relates to compositions containing chemical compounds and compositions and pharmaceutical formulations of the compounds which increase the expression of total...
US20150150976 PHENYLEPHRINE-CONTAINING LIQUID FORMULATIONS  
An oral, aqueous-based, liquid pharmaceutical composition is provided. The composition comprises up to about 45% glycerin and up to about 10% sorbitol wherein the glycerin to sorbitol ratio is...
US20110027397 METHODS OF TREATING AUTISM SPECTRUM DISORDERS AND COMPOSITIONS FOR SAME  
Disclosed are compositions that inhibit brain blood vessel leakage, compositions for treating autism spectrum disorders, methods of treating autism spectrum disorders, and methods of screening for...
US20130217685 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR  
The invention relates to compositions and methods for inhibiting RNA binding proteins (e.g., MEX-3, MEX-5 and POS-1), as well as methods for treating and preventing disorders associated with...
US20110065704 COMPOUNDS FOR MODULATING RNA BINDING PROTEINS AND USES THEREFOR  
The invention relates to compositions and methods for inhibiting RNA binding proteins (e.g., MEX-3, MEX-5 and POS-1), as well as methods for treating and preventing disorders associated with...
US20130109674 METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE, AND VASCULAR CONDITIONS  
The present invention relates to, among other things, methods for treating trigeminal cephalgias such as migraine and migraine like headaches and other cerebrovascular conditions associated with...
US20120077836 METHODS OF ADMINISTERING (4AR,10AR)-1-N-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO [G] QUINOLINE-6,7-DIOL AND RELATED COMPOUNDS ACROSS THE ORAL MUCOSA, THE NASAL MUCOSA OR THE SKIN AND PHARMACEUTICAL COMPOSITIONS THEREOF  
Disclosed are pharmaceutical compositions and methods for the administration of (4aR,10aR)-1-n-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g] quinoline-6,7-diol or a pharmaceutically acceptable...
US20120301544 PHARMACEUTICAL FORMULATIONS OF LORATADINE FOR ENCAPSULATION AND COMBINATIONS THEREOF  
This invention relates to a loratadine formulation suitable for encapsulation into a soft gel capsule or suitable dosage unit improved functionality providing enhanced in vitro dissolution and...
US20150133442 METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1  
The invention features compositions and methods for inhibiting the Pin1 protein, and the treatment of disorders characterized by elevated Pin1 levels.
US20120022094 PHARMACEUTICAL FORMULATIONS  
New and improved antihistaminic syrups are disclosed.
US20050288283 Topical formulations for treating allergic diseases  
Methods for topically treating allergic diseases of the eye, ear or nose using tricyclic compounds are disclosed.
US20120041018 OCTAHYDROBENZOISOQUINOLINE MODULATORS OF DOPAMINE RECEPTORS AND USES THEREFOR  
Octahydrobenzoisoquinoline modulators of dopamine receptors are described herein. Methods for using octahydrobenzoisoquinoline modulators of dopamine receptors in the treatment of dopamine...
US20110071185 MANUFACTURE OF TABLET IN A DIE UTILIZING POWDER BLEND CONTAINING WATER-CONTAINING MATERIAL  
The present invention features the present invention features a process for making a tablet by compacting a powder blend in a die platen to form a tablet shape, wherein the powder blend includes a...
US20140213563 METHODS OF DIAGNOSING AND TREATING NEONATAL REVERSION TO FETAL CONSCIOUSNESS  
This invention provides methods of diagnosing and treating syndromes of reversion to fetal consciousness in a neonate.
US20110318411 MULTI-LAYERED ORALLY DISINTEGRATING TABLET AND THE MANUFACTURE THEREOF  
The present invention features a tablet containing a first layer and a second layer, wherein: (i) the first layer includes a pharmaceutically active agent and the composition of the first layer is...
US20120141467 Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma  
Provided herein is a method for treating a tracheo-bronchial-alveolar tract disease in a subject in need thereof, the method comprising the step of administering to a subject in need of such...
US20130203762 VETERINARY ANTIPROLACTINIC COMPOSITION FOR RUMINANTS  
This present invention relates to an antiprolactinic veterinary composition to be administered to ruminants. Said composition comprises at least one antiprolactinic compound which is an agonist of...
US20110319441 MANUFACTURE OF VARIABLE DENSITY DOSAGE FORMS UTILIZING RADIOFREQUENCY ENERGY  
The present invention features the present invention features a tablet including at least one pharmaceutically active ingredient, wherein the shape of said tablet includes at least one major face...
US20110092533 COMPOUNDS FOR BINDING TO ER ALPHA/BETA AND GPR30, METHODS OF TREATING DISEASE STATES AND CONDITIONS MEDIATED THROUGH THESE RECEPTORS AND IDENTIFICATION THEREOF  
The current invention is in the field of molecular biology/pharmacology and provides compounds which modulate the effects of GPR30 as well as the classical estrogen receptors alpha and beta (ERĪ±...
US20150191495 ANTIDIABETIC TRICYCLIC COMPOUNDS  
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment,...
US20140045746 ANTIDIABETIC TRICYCLIC COMPOUNDS  
Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment,...
US20120130147 METHODS FOR THE TREATMENT OF TUMORS WITH INDANE COMPOUNDS  
Compounds of the formula (I), in which R1, R2, R3, R4, and q have the meanings indicated in Claim 1, can be employed, inter alia, for the treatment of tumours.
US20140113927 TREATMENT UTILIZING HYDROPHOBIC WEAK BASES CHEMOTHERAPEUTIC AGENTS AND ILLUMINATION  
Hydrophobic weak base compounds such as hydrophobic weak base chemotherapeutic agents (which are not an anthracycline) for use in the treatment of medical conditions such as proliferative disease...
US20130267502 Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors  
This disclosure is directed to treatment of addictions and primary impulse-control disorders using phosphodiesterase 7 (PDE7) inhibitors, alone or in combination with other therapeutic agents.
US20120108624 TREATMENT OF DYSKINESIA RELATED DISORDERS  
Disclosed herein are methods of treating Parkinsons disease while maintaining a low dyskinesia induction profile and methods of reversing dyskinesias comprising administering a therapeutically...
US20120010233 METHODS AND COMPOSITIONS TO INHIBIT EDEMA FACTOR AND ADENYLYL CYCLASE  
Small molecules and their derivatives are described for the treatment and/or prevention of intestinal fluid loss. Also disclosed are methods of using said molecules and their derivatives to treat...
US20050203117 Treating allergic and inflammatory conditions  
Methods of using desloratadine for substantially returning work-related performance and workplace productivity of a person suffering from an allergic and/or inflammatory condition of the skin...
US20120220568 Histamine-3 Receptor Antagonists  
This invention is directed to a compound of formula I, wherein R1, R2, R4, R5, R6, R7, R8 and n are as defined herein, or a pharmaceutically acceptable salt thereof; a pharmaceutical composition...
US20060079540 Pde4 and pde3/4 inhibitors for use in the treatment of cachexia  
The invention relates to the use of a PDE4 or PDE3/4 inhibitor for the treatment of cachexia.
US20140148377 Emetine Derivatives, Prodrugs Containing Same, And Methods Of Treating Conditions Using Same  
Compounds are provided herein which are emetine derivatives that can be used as prodrugs which selectively undergo activation to release emetine in specific cellular conditions. In one aspect, a...
US20110112098 MOLECULES INHIBITING A METABOLIC PATHWAY INVOLVING THE SYK PROTEIN TYROSINE KINASE AND METHOD FOR IDENTIFYING SAID MOLECULES  
The present invention relates to the C-13 molecule (methyl 2-{5-[(3-benzyl-4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)met hyl]-2-furyl}-benzoate) and to organic molecules functionally equivalent to...
US20140378398 PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS  
The invention relates to a pharmaceutical combination comprising the compound of formula I or pharmaceutically acceptable salts thereof in combination with at least one second therapeutic agent 2....
US20130303446 PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS  
The invention relates to a pharmaceutical combination comprising the compound of formula I or pharmaceutically acceptable salts thereof in combination with at least one second therapeutic agent 2....
US20110071136 NOVEL TRICYCLIC PROTEIN KINASE MODULATORS  
The invention provides compounds that inhibit CK2 and/or Pim kinases and compositions containing such compounds. These tricyclic compounds and compositions containing them are useful for treating...
US20080293693 Treatment or Prevention of Ovarian Hyperstimulation Syndrome (Ohss) Using a Dopamine Agonist  
Disclosed herein is a method for preventing ovarian hyperstimulation syndrome in a subject by administering an effective amount of a dopamine agonist in a pharmaceutically acceptable carrier. Also...
US20110092514 COMPOUNDS WITH ANTI-CANCER ACTIVITY  
Novel substituted azole diones are provided that kill cells, suppress cell proliferation, suppress cell growth, abrogate the cell cycle G2 checkpoint and/or cause adaptation to G2 cell cycle...
US20080207593 Antihistamine Combination  
A once daily formulation containing the combination of a non-sedating or selective antihistamine (Loratadine) with a sedating or non-selective antihistamine (Chlorpheniramine) administered at...
US20090081314 Glycemic Control, Diabetes Treatment, and Other Treatments with Acetyl Cholinesterase Inhibitors  
There is disclosed a method for glycemic control of a patient having a disease selected from the group consisting of type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance,...
US20100330150 Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs  
The present invention is directed to pharmaceutical compositions comprising a plurality of taste-masked high-dose/low-dose drug-containing microparticles, dosage forms comprising such...
US20130274283 PREMATURE-TERMINATION-CODONS READTHROUGH COMPOUNDS  
Premature termination codons readthrough compounds, composition thereof, and methods of making and using the same are provided.
US20080242657 Treatment of Tremor with Histamine H3 Inverse Agonists or Hist Amine H3 Antagonists  
Histamine H3 inverse agonists or histamine H3 antagonists are useful, alone or in combination with a neuroleptic agent, for treating or preventing movement disorders, including tremor, such as...

Matches 1 - 50 out of 318 1 2 3 4 5 6 7 >